Fair Value Calculator Fair Value Calculator
EN DE

2582 (2582) Fair Value & Analysis

Industrials · Market cap HK$1.6B

2 2582 2582 · HK
PriceHK$12.46
Fair ValueHK$9.28
Upside-25.5%
Quality14/100
Watch 2582 for free — get notified when fair value or trend changes. Watch for free
Evidence: Low Range HK$6.92 – HK$13.85

Fair value as of: Jul 2, 2026

From 1 valuation models · updated today

Share price −42.8% over the past month.

Price vs Fair Value (12 months)

HK$111.60 HK$11.87 Fair Value HK$9.28 Jun 2025 Jul 2026

12‑month range HK$11.87 – HK$111.60 · fair‑value band HK$6.92 – HK$13.85 · the HK$12.46 price screens above the HK$9.28 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

2582 (2582) currently trades at HK$12.46, while our model-based Fair Value estimate is HK$9.28 — implying the stock looks roughly 25.5% overvalued today. We read business quality at 14/100 (below-average quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

Trailing-twelve-month revenue stands at HK$346M. Revenue declined 26.7% year over year. It earns a return on equity of -34.3%. Net debt stands at HK$565M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$346M
Revenue growth (YoY) -26.7%
Net margin -111%
Return on equity -34.3%
Free cash flow −HK$321M FY2025
Operating margin -70.8%
More key figures
EPS (TTM) HK$-0.8500
Net debt HK$565M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

2582 reported revenue of HK$337M in FY2025 versus HK$329M in FY2021, a compound +0.6%/yr. Reported net income was −HK$373M in FY2025.

Revenue +0.6%/yr
FY21 HK$329M
FY22 HK$359M
FY23 HK$522M
FY24 HK$459M
FY25 HK$337M
Net income
FY21 −HK$71.2M
FY22 −HK$93.9M
FY23 −HK$73.3M
FY24 −HK$210M
FY25 −HK$373M

Is 2582 fairly valued? → Check now

Similar stocks

6 more Specialty Industrial Machinery stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock Price Fair Value vs Fair Value
GE Vernova Inc GEV $1,128 $185.61 -84%
SIEGY SIEGY $155.10 $88.93 -43%
SMAWF SMAWF $307.12 $176.28 -43%
SMNS SMNS C$31.76 C$22.85 -28%
SIE SIE €279.00 €140.38 -50%
Schneider Electric S.E. SBGSF $334.00 $148.44 -56%

Explore undervalued stocks

More undervalued Industrials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is 2582 (2582) undervalued?
As of Jul 2, 2026, our model estimates a fair value of HK$9.28 versus a price of HK$12.46 — about −26% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 2582?
Our model-based fair value for 2582 is HK$9.28 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$12.46.
What is the quality score of 2582?
2582 has a Quality Score of 14/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of 2582 (2582)?
2582 reported trailing-twelve-month revenue of about HK$346M (latest available figure, as of Jul 2, 2026).
What is the net profit margin of 2582?
The net profit margin of 2582 is about -110.6%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.